These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39028491)

  • 1. Alpha-galactosylceramide pre-treatment attenuates clinical symptoms of LPS-induced acute neuroinflammation by converting pathogenic iNKT cells to anti-inflammatory iNKT10 cells in the brain.
    Kim TC; Park HJ; Lee SW; Park YH; Van Kaer L; Hong S
    Inflamm Res; 2024 Sep; 73(9):1511-1527. PubMed ID: 39028491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The iNKT cell ligand α-GalCer prevents murine septic shock by inducing IL10-producing iNKT and B cells.
    Park YH; Lee SW; Kim TC; Park HJ; Van Kaer L; Hong S
    Front Immunol; 2024; 15():1457690. PubMed ID: 39355237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltration of invariant natural killer T cells occur and accelerate brain infarction in permanent ischemic stroke in mice.
    Wang ZK; Xue L; Wang T; Wang XJ; Su ZQ
    Neurosci Lett; 2016 Oct; 633():62-68. PubMed ID: 27637387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma.
    Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
    J Biol Chem; 2019 Apr; 294(14):5438-5455. PubMed ID: 30745361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graphene oxide polarizes iNKT cells for production of TGFβ and attenuates inflammation in an iNKT cell-mediated sepsis model.
    Lee SW; Park HJ; Van Kaer L; Hong S; Hong S
    Sci Rep; 2018 Jul; 8(1):10081. PubMed ID: 29973666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice.
    Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
    J Cell Mol Med; 2019 Feb; 23(2):1072-1085. PubMed ID: 30421497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization.
    Goto T; Ito Y; Satoh M; Nakamoto S; Nishizawa N; Hosono K; Naitoh T; Eshima K; Iwabuchi K; Hiki N; Amano H
    Front Immunol; 2021; 12():754106. PubMed ID: 34691073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling.
    Emoto M; Shimizu T; Koike H; Yoshizawa I; Hurwitz R; Kaufmann SH; Emoto Y
    Immunology; 2010 Jan; 129(1):62-74. PubMed ID: 20028429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer.
    Wang Y; Bhave MS; Yagita H; Cardell SL
    Front Immunol; 2020; 11():581301. PubMed ID: 33193386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease of spleen invariant natural killer T and natural killer cell numbers in Burkholderia thailandensis-infected C57BL/6 mice.
    Kasetthat T; Sermswan RW; Ren Y; Watarai H; Wongratanacheewin S
    Asian Pac J Allergy Immunol; 2022 Jun; 40(2):155-161. PubMed ID: 31586487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iNKT Cell Activation Exacerbates the Development of Huntington's Disease in R6/2 Transgenic Mice.
    Park HJ; Lee SW; Im W; Kim M; Van Kaer L; Hong S
    Mediators Inflamm; 2019; 2019():3540974. PubMed ID: 30766446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of invariant natural killer T cells in regional lymph nodes as new antigen-specific immunotherapy via induction of interleukin-21 and interferon-γ.
    Sakurai T; Inamine A; Iinuma T; Funakoshi U; Yonekura S; Sakurai D; Hanazawa T; Nakayama T; Ishii Y; Okamoto Y
    Clin Exp Immunol; 2014 Oct; 178(1):65-74. PubMed ID: 24943738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride.
    Park O; Jeong WI; Wang L; Wang H; Lian ZX; Gershwin ME; Gao B
    Hepatology; 2009 May; 49(5):1683-94. PubMed ID: 19205035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Invariant Natural Killer T Cell Subsets in C57BL/6J Mice by Different Injection Modes of α-galactosylceramide.
    Meng M; Chen S; Gao X; Liu H; Zhao H; Zhang J; Zhang J; Chen D
    Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):35-44. PubMed ID: 32245319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza.
    Barthelemy A; Ivanov S; Hassane M; Fontaine J; Heurtault B; Frisch B; Faveeuw C; Paget C; Trottein F
    mBio; 2016 Nov; 7(6):. PubMed ID: 27803187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans.
    Abe M; Kinjo Y; Sadamoto S; Shinozaki M; Nagi M; Shibuya K; Miyazaki Y
    PLoS One; 2021; 16(11):e0259306. PubMed ID: 34784362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated accumulation of regulatory T cells and reduced production of interleukin 10 lead to the exacerbation of tissue injury in a mouse model of acute respiratory distress syndrome.
    Toyama M; Kudo D; Aoyagi T; Miyasaka T; Ishii K; Kanno E; Kaku M; Kushimoto S; Kawakami K
    Microbiol Immunol; 2018 Feb; 62(2):111-123. PubMed ID: 29266409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy.
    Wang Y; Sedimbi SK; Löfbom L; Besra GS; Porcelli SA; Cardell SL
    Front Immunol; 2019; 10():352. PubMed ID: 30881361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-γ.
    Wang H; Feng D; Park O; Yin S; Gao B
    Hepatology; 2013 Oct; 58(4):1474-85. PubMed ID: 23686838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.